Tag: Drug Approvals
FDA Permits Marketing of New Device for Treating GI Bleeding
Hemospray is an aerosolized spray that delivers a mineral blend to the bleeding site
FDA Approves Drug Combo for Aggressive Thyroid Cancer
Dabrafenib + trametinib approved to treat BRAF-positive anaplastic thyroid cancer
Women’s Representation in CVD Drug Trials Varies
Representation in desired range for hypertension, atrial fibrillation but low for heart failure, CAD
FDA Approves First Drug for Rare Form of Rickets
Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia
FDA Approves First Auto-Darken Contact Lenses
Acuvue Oasys contact lenses with light-adaptive technology are soft contact lenses made for daily use
FDA Approves Mechanical Heart Valve for Newborns
Masters Series Mechanical Heart Valve now available in smallest size yet
FDA Approves First Screening Tests for Tickborne Parasite
Babesia microti screening tests will help reduce risk of transfusion-transmitted infection
FDA Approves New Medication for Drug-Resistant HIV
Trogarzo is given intravenously once every 14 days in combination with other antiretrovirals
FDA Approves First Blood Test to Evaluate Potential Concussions
Should help reduce unnecessary CT testing and associated radiation exposure
FDA Approves Erleada to Treat Non-Metastatic Prostate Cancer
First FDA-approved treatment for non-metastatic, castration-resistant prostate cancer
